Find Estradiol Acetate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

6 RELATED EXCIPIENT COMPANIES

12EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Femring, Femtrace, Estradiol 3-acetate, Estradiol-3-acetate, 4245-41-4, Estradiol acetate [usan]
Molecular Formula
C20H26O3
Molecular Weight
314.4  g/mol
InChI Key
FHXBMXJMKMWVRG-SLHNCBLASA-N
FDA UNII
5R97F5H93P

Estradiol Acetate
Estradiol Acetate is the acetate salt form of estradiol, the most potent, naturally produced estrogen. Estradiol acetate diffuses through the cell membrane and binds to and subsequently activates the nuclear estrogen receptor found in the reproductive tract, breast, pituitary, hypothalamus, liver, and bone. The activated complex binds to the estrogen response element on the DNA and activates the transcription of genes involved in the functioning of the female reproductive system and secondary sex characteristics.
1 2D Structure

Estradiol Acetate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate
2.1.2 InChI
InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1
2.1.3 InChI Key
FHXBMXJMKMWVRG-SLHNCBLASA-N
2.1.4 Canonical SMILES
CC(=O)OC1=CC2=C(C=C1)C3CCC4(C(C3CC2)CCC4O)C
2.1.5 Isomeric SMILES
CC(=O)OC1=CC2=C(C=C1)[C@H]3CC[C@]4([C@H]([C@@H]3CC2)CC[C@@H]4O)C
2.2 Other Identifiers
2.2.1 UNII
5R97F5H93P
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Femring

2. Femtrace

3. Estradiol 3-acetate

4. Estradiol-3-acetate

5. 4245-41-4

6. Estradiol Acetate [usan]

7. E3a

8. 5r97f5h93p

9. Estradiol Acetate (usan)

10. Dsstox_cid_25867

11. Dsstox_rid_81186

12. Dsstox_gsid_45867

13. [(8r,9s,13s,14s,17s)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] Acetate

14. Menoring

15. Cas-4245-41-4

16. 3-o-acetylestradiol

17. Estradiol, 3-acetate

18. 17beta-estradiol 3-acetate

19. Unii-5r97f5h93p

20. E 3a

21. Estradiol-acetate

22. Femring (tn)

23. 3-acetoxyestra-1,3,5(10)-trien-17beta-ol

24. 17beta-hydroxy-3-acetoxyestra-1,3,5(10)-triene

25. Schembl148561

26. Estra-1,3,5(10)-triene-3,17beta-diyl 3-acetate

27. Chembl1200430

28. Dtxsid7045867

29. Estradiol Acetate [vandf]

30. Chebi:135981

31. Estradiol 3-acetate [mi]

32. Estradiol Acetate [mart.]

33. Estradiol Acetate [who-dd]

34. Tox21_111359

35. Tox21_113661

36. Db13952

37. Estradiol Acetate [orange Book]

38. Ncgc00249885-01

39. D04061

40. 3-acetoxy-oestra-1,3,5(10)-trien-17beta-ol

41. 17beta-hydroxyestra-1,3,5(10)-trien-3-yl Acetate

42. 3-(acetyloxy)estra-1,3,5(10)-trien-17.beta.-ol

43. Q27262772

44. 17.beta.-hydroxyestra-1,3,5(10)-trien-3-yl Acetate

45. Estra-1,3,5(10)-triene-3,17-diol, (17beta)-, 3-acetate

46. Estra-1,3,5(10)-triene-3,17-diol, (17 Beta)-, 3-acetate

47. Estra-1,3,5(10)-triene-3,17-diol, (17.beta.)-, 3-acetate

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 314.4 g/mol
Molecular Formula C20H26O3
XLogP32.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass314.18819469 g/mol
Monoisotopic Mass314.18819469 g/mol
Topological Polar Surface Area46.5 Ų
Heavy Atom Count23
Formal Charge0
Complexity476
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Femring is indicated for the treatment of vasomotor and urogenital symptoms associated with menopause. Use of Femring (estradiol acetate) has been shown to improve symptoms caused by atrophy of the vagina (such as dryness, burning, pruritus and dyspareunia) and/or the lower urinary tract (urinary urgency and dysuria).


FDA Label


5 Pharmacology and Biochemistry
5.1 Pharmacology

Estrogen mediates its effects across the body through potent agonism of the Estrogen Receptor (ER), which is located in various tissues including in the breasts, uterus, ovaries, skin, prostate, bone, fat, and brain. Estradiol binds to both subtypes of the Estrogen Receptor: Estrogen Receptor Alpha (ER) and Estrogen Receptor Beta (ER). Estradiol also acts as a potent agonist of G Protein-coupled Estrogen Receptor (GPER), which has recently been recognized as a major mediator of estradiol's rapid cellular effects.


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Estrogen Receptor Agonists [MoA]; Estrogen [EPC]; Estradiol Congeners [CS]
5.3 Absorption, Distribution and Excretion

Absorption

Drug delivery from Femring is rapid for the first hour and then declines to a relatively constant rate for the remainder of the 3-month dosing interval. Estradiol acetate is rapidly hydrolyzed to estradiol which is absorbed through the vaginal mucosa as evidenced by the mean time to maximum concentration (tmax) for estradiol of about 1 hour (range 0.25 to 1.5 hrs). Following the maximum concentration (Cmax=1129pg/mL), serum estradiol decreases rapidly such that by 24 to 48 hours postdose, serum estradiol concentrations are relatively constant through the end of the 3-month dosing interval.


Route of Elimination

Estradiol, estrone and estriol are excreted in the urine along with glucuronide and sulfate conjugates.


Volume of Distribution

The distribution of exogenous estrogens is similar to that of endogenous estrogens. Estrogens are widely distributed in the body and are generally found in higher concentrations in the sex hormone target organs.


5.4 Metabolism/Metabolites

Exogenous estrogens are metabolized using the same mechanism as endogenous estrogens. Estradiol is converted reversibly to estrone, and both can be converted to estriol, which is the major urinary metabolite. Estrogens also undergo enterohepatic recirculation via sulfate and glucuronide conjugation in the liver, biliary secretion of conjugates into the intestine, and hydrolysis in the gut followed by reabsorption. In postmenopausal women, a significant proportion of the circulating estrogens exist as sulfate conjugates, especially estrone sulfate, which serves as a circulating reservoir for the formation of more active estrogens.


Estradiol acetate has known human metabolites that include 6-[(3-acetyloxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid.

S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560


5.5 Mechanism of Action

Estradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary. Increases in the down-stream effects of ER binding reverses some of the symptoms of menopause, which are primarily caused by a loss of estrogenic activity.


DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - INSERT, EXTENDED RELEASE;VAGINAL - E...DOSAGE - INSERT, EXTENDED RELEASE;VAGINAL - EQ 0.05MG BASE/24HR

USFDA APPLICATION NUMBER - 21367

read-more

DOSAGE - INSERT, EXTENDED RELEASE;VAGINAL - E...DOSAGE - INSERT, EXTENDED RELEASE;VAGINAL - EQ 0.1MG BASE/24HR

USFDA APPLICATION NUMBER - 21367

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Direct Compression

read-more
read-more

Lubricants & Glidants

read-more
read-more

Emulsifying Agents

read-more
read-more

Co-Processed Excipients

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

API Stability Enhancers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Estradiol Acetate Manufacturers

A Estradiol Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Estradiol Acetate, including repackagers and relabelers. The FDA regulates Estradiol Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Estradiol Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Estradiol Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Estradiol Acetate Suppliers

A Estradiol Acetate supplier is an individual or a company that provides Estradiol Acetate active pharmaceutical ingredient (API) or Estradiol Acetate finished formulations upon request. The Estradiol Acetate suppliers may include Estradiol Acetate API manufacturers, exporters, distributors and traders.

click here to find a list of Estradiol Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Estradiol Acetate USDMF

A Estradiol Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Estradiol Acetate active pharmaceutical ingredient (API) in detail. Different forms of Estradiol Acetate DMFs exist exist since differing nations have different regulations, such as Estradiol Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Estradiol Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Estradiol Acetate USDMF includes data on Estradiol Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Estradiol Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Estradiol Acetate suppliers with USDMF on PharmaCompass.

Estradiol Acetate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Estradiol Acetate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Estradiol Acetate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Estradiol Acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Estradiol Acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Estradiol Acetate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Estradiol Acetate suppliers with NDC on PharmaCompass.

Estradiol Acetate GMP

Estradiol Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Estradiol Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Estradiol Acetate GMP manufacturer or Estradiol Acetate GMP API supplier for your needs.

Estradiol Acetate CoA

A Estradiol Acetate CoA (Certificate of Analysis) is a formal document that attests to Estradiol Acetate's compliance with Estradiol Acetate specifications and serves as a tool for batch-level quality control.

Estradiol Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Estradiol Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Estradiol Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Estradiol Acetate EP), Estradiol Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Estradiol Acetate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty